Kevin Bitterman Transaction History

Date Transaction Value Shares Traded Form
Jun 01 2021
SELL
Open market or private sale
$459,611 $26.28 p/Share
17,489
Oct 09 2020
SELL
Open market or private sale
$376,090 $28.93 p/Share
13,000

Also insider at

GMTX
Gemini Therapeutics, Inc. Healthcare
KB

Kevin Bitterman

Director
South San Francisco, CA

Track Institutional and Insider Activities on AKRO

Follow Akero Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKRO shares.

Notify only if

Insider Trading

Get notified when an Akero Therapeutics, Inc. insider buys or sells AKRO shares.

Notify only if

News

Receive news related to Akero Therapeutics, Inc.

Track Activities on AKRO